CS logo
small CS logo
SCIderm GmbH

Hamburg, Germany
Corporate office
Anckelmannspl. 1, 20537 Hamburg

About SCIderm GmbH


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
LEO Pharma
3
Amgen
1
Forward-Pharma GmbH
1
Janssen Research & Development, LLC
1
Janssen-Cilag G.m.b.H
1
Johnson & Johnson Consumer and Personal Products Worldwide
1
MEDA Pharma GmbH & Co. KG
1
Merz Pharmaceuticals GmbH
1
photonamic GmbH & Co. KG
1
Total Rows: 9

Clinical Trials at SCIderm GmbH


During the past decade, SCIderm GmbH conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years440011000011Started TrialsCompleted Trails2017201820190246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK
2006-03-01
2007-12-01
Completed
107
Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines
2007-06-18
2009-12-28
Completed
801
Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses
2008-12-01
2012-11-01
Completed
258
Hydrogel Blister Patch Prototype Treatment for Foot Blisters on the Heel
2010-03-01
2010-11-01
Completed
93
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
2010-09-01
2012-05-01
Completed
252
Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
2012-10-01
2016-04-04
Completed
250
LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris
2017-02-15
2019-06-26
Completed
722
A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis
2017-04-27
2018-09-20
Completed
1,048

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "SCIderm GmbH" #1 sponsor was "LEO Pharma" with 3 trials, followed by "Amgen" with 1 trials sponsored, "Forward-Pharma GmbH" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Janssen-Cilag G.m.b.H" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsLEO Pharma: 3LEO Pharma: 3Amgen: 1Amgen: 1Forward-Pharma GmbH: 1Forward-Pharma GmbH: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1Janssen-Cilag G.m.b.H: 1Janssen-Cilag G.m.b.H: 1Johnson & JohnsonConsumer and PersonalProducts Worldwide: 1Johnson & JohnsonConsumer and PersonalProducts Worldwide: 1MEDA Pharma GmbH &Co. KG: 1MEDA Pharma GmbH &Co. KG: 1Merz Pharmaceuticals GmbH: 1Merz Pharmaceuticals GmbH: 1photonamic GmbH & Co. KG: 1photonamic GmbH & Co. KG: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at SCIderm GmbH


According to Clinical.Site data, the most researched conditions in "SCIderm GmbH" are "Psoriasis" (3 trials), "Actinic Keratosis" (2 trials), "Psoriasis Vulgaris" (2 trials), "Atopic Dermatitis" (1 trials) and "Blister" (1 trials). Many other conditions were trialed in "SCIderm GmbH" in a lesser frequency.

Clinical Trials Intervention Types at SCIderm GmbH


Most popular intervention types in "SCIderm GmbH" are "Drug" (9 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Guselkumab" (2 trials), "Apremilast" (1 trials), "Brodalumab" (1 trials) and "Diclofenac" (1 trials). Other intervention names were less common.

Clinical Trials Genders at SCIderm GmbH


The vast majority of trials in "SCIderm GmbH" are 11 trials for "All" genders.

Clinical Trials Status at SCIderm GmbH


Currently, there are NaN active trials in "SCIderm GmbH". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in SCIderm GmbH, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SCIderm GmbH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 4: 2Phase 4: 2Not Applicable: 1Not Applicable: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 10Completed: 10Active, not recruiting: 1Active, not recruiting: 1